Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Attendee list released for Orphan Drugs & Rare Diseases 2016

SMi Group
Posted on: 14 Sep 16
Attendee list released for Orphan Drugs & Rare Diseases 2016

SMi Reports (13.09. 2016, London, UK): Alexion, BioMarin, Chiesi, MHRA, NICE to meet in London in October to discuss updates in the orphan drug landscape.

A preliminary list of delegates for SMi's 5th Orphan Drugs & Rare Diseases Conference has been released. Representatives from over 30 organisations shaping up the orphan drug landscape will gather at the two-day event which takes place on 19 & 20 October in Central London.

Confirmed attendees include industry experts from Abeona, AKU Society, Alexion, BioMarin, Boehringer Mannheim, Chiesi, ClinTec International, Findacure, INC Research, Mereo BioPharma, MHRA, NICE, Quintiles, Shire, The Birmingham Children's Hospital, and many more. The full list of delegates can be viewed on the event website at http://www.orphandrugs-event.com.

This year’s programme will feature 20+ industry-led and case-study driven presentations, a panel discussion plus two interactive pre-conference workshops.

Teaming up with key movers and shakers within the industry, SMi has tailored the conference programme to bring up key topics such as strategies to accelerate orphan drug development; market access, pricing and reimbursement; addressing challenges in defending orphan drugs pricing; patient groups' perspectives on patient recruitment and retention; gene and cell therapy treatments; and regulatory updates for orphan products with a focus on emerging markets.

The event will also feature two interactive workshops: "Planning for success: Developing the optimal orphan drug development strategy" led by Cell Medica and Chiesi and "Paving the way for achieving orphan drug market access" led by RJW & Partners.

A detailed programme is available to view on the event website.

For those interested in attending Orphan Drugs 2016, registration is live online at http://www.orphandrugs-event.com.

 

5th Orphan Drugs & Rare Diseases Conference and Exhibition
19-20 October 2016, London UK
http://www.orphandrugs-event.com

-------------------------END --------------------------

Contact Information:

For those interested to speak or to exhibit at the event, please contact Alia Malick on +44(0)207 827 6168 or amalick@smi-online.co.uk. For delegate enquiries, please contact Matt Apps on +44(0)207 827 6093 or mapps@smi-online.co.uk.For media enquiries please contact Honey de Gracia on +44(0)207 827 6102 or hdegracia@smi-online.co.uk.

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

 

 

For more information:
www.orphandrugs-event.com/pharmiweb

Editor's Details

Honey de Gracia
SMi Group
www.orphandrugs-event.com/pharmiweb
02078276102
hdegracia@smi-online.co.uk

Last updated on: 14/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.